MedTrace Logo

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

NCT02680717 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2018-07-18

No results posted yet for this study

Summary

This is a study designed to evaluate the comparative effectiveness of topical medications for the treatment of circumscribed morphea.

Conditions

  • Scleroderma

Interventions

DRUG

Clobetasol

ointment, twice daily (alternating weeks)

DRUG

Calcipotriene

ointment, twice daily

DRUG

Tacrolimus

ointment, 0.1%, twice daily

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Seattle Children's Hospital

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Yvonne Chiu, MD · Medical College of Wisconsin

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-05-31
Completion
2017-05-31

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02680717 on ClinicalTrials.gov